Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Boffa

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Journal of Clinical Lipidology|October 15, 2018
Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisalMichael B Boffa, Saverio Stranges, Neil Klar, et al.
The Journal of Biological Chemistry|May 10, 2002
A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitorMichael B Boffa, Jeffrey D Hamill, Nazareth Bastajian, et al.
Biochemistry|January 12, 2005
Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10Andrea R Belczewski, Janet Ho, Fletcher B Taylor, et al.
The Journal of Biological Chemistry|March 18, 2015
Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptorRocco Romagnuolo, Corey A Scipione, Michael B Boffa, et al.
Cytokine|January 6, 2012
Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding siteMathieu Garand, Joellen H H Lin, Ceredwyn E Hill, et al.
Journal of Thrombosis and Haemostasis : JTH|February 9, 2023
Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysisZe Zheng, Liliya Mukhametova, Michael B Boffa, et al.
Journal of Lipid Research|October 18, 2015
Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)Corey A Scipione, Sera E Sayegh, Rocco Romagnuolo, et al.
The Journal of Biological Chemistry|March 21, 2003
Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cellsMichael B Boffa, Jeffrey D Hamill, Deborah Maret, et al.
Plos One|July 28, 2017
Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9Rocco Romagnuolo, Corey A Scipione, Santica M Marcovina, et al.
BMC Cancer|May 26, 2016
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysisZainab A Bazzi, Danielle Lanoue, Mouhanned El-Youssef, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Lipidology|October 15, 2018
Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisalMichael B Boffa, Saverio Stranges, Neil Klar, et al.
The Journal of Biological Chemistry|May 10, 2002
A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitorMichael B Boffa, Jeffrey D Hamill, Nazareth Bastajian, et al.
Biochemistry|January 12, 2005
Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10Andrea R Belczewski, Janet Ho, Fletcher B Taylor, et al.
The Journal of Biological Chemistry|March 18, 2015
Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptorRocco Romagnuolo, Corey A Scipione, Michael B Boffa, et al.
Cytokine|January 6, 2012
Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding siteMathieu Garand, Joellen H H Lin, Ceredwyn E Hill, et al.
Journal of Thrombosis and Haemostasis : JTH|February 9, 2023
Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysisZe Zheng, Liliya Mukhametova, Michael B Boffa, et al.
Journal of Lipid Research|October 18, 2015
Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)Corey A Scipione, Sera E Sayegh, Rocco Romagnuolo, et al.
The Journal of Biological Chemistry|March 21, 2003
Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cellsMichael B Boffa, Jeffrey D Hamill, Deborah Maret, et al.
Plos One|July 28, 2017
Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9Rocco Romagnuolo, Corey A Scipione, Santica M Marcovina, et al.
BMC Cancer|May 26, 2016
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysisZainab A Bazzi, Danielle Lanoue, Mouhanned El-Youssef, et al.
Pageof 8